HIV Infection in Humanized Mice
$376,655ZIAFY2014AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications, trials & patents
Paper 30770827Paper 30085162Paper 29447279Paper 29112072Paper 27099312Paper 26670361Paper 26609939Paper 26529416Paper 24021673Patent 9771428Patent 11780931Patent 11230607Patent 10723803Patent 10184004
Abstract
This project resulted in two peer-reviewed journal publications in FY2014. We established an improved humanized mouse model for the study of immune responses to HIV infection and vaccination. The model utilizes severely immunocompromised mice reconstituted with human thymic and liver tissue, which establishes human lymphocytic and monocytic populations susceptible to HIV infection. The mice support both intravenous and mucosal HIV infection and develop HIV-specific B and T cell immunity. A distinct advantage of this model is that the mice do not develop graft versus host disease and can therefore be used in long-term studies of HIV infection not previously possible.
View original record on NIH RePORTER →